Carol Aghajanian

Carol Aghajanian

UNVERIFIED PROFILE

Are you Carol Aghajanian?   Register this Author

Register author
Carol Aghajanian

Carol Aghajanian

Publications by authors named "Carol Aghajanian"

Are you Carol Aghajanian?   Register this Author

100Publications

3226Reads

34Profile Views

Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer.

Gynecol Oncol 2019 10 14;155(1):51-57. Epub 2019 Aug 14.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States of America; Department of Medicine, Weill Cornell Medical College, New York, NY, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.08.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788969PMC
October 2019

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.

N Engl J Med 2019 Sep 28. Epub 2019 Sep 28.

From the University of Texas M.D. Anderson Cancer Center, Houston (R.L.C.); University of Chicago Medicine (G.F.F.) and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University (D.C.), Chicago, and AbbVie, North Chicago (D.M.S., B.A.B., S.B., C.K.R., P.J.A., M.H.D.) - all in Illinois; NRG Oncology Statistical and Data Center, Roswell Park Cancer Institute, Buffalo (M.F.B.), and Memorial Sloan Kettering Cancer Center, New York (K.B.-M., C.A.) - both in New York; University of Washington-Seattle Cancer Care Alliance, Seattle (E.M.S.); Lillebaelt University Hospital of Southern Denmark, Vejle, and the University of Southern Denmark, Odense (K.D.S.); Prince of Wales Clinical School, University of New South Wales and Royal Hospital for Women (M.F.), and the Northern Cancer Institute (S.B.-H.), Sydney; Jikei University School of Medicine, Tokyo (A. Okamoto), and Aichi Cancer Center Hospital, Nagoya (M.M.) - both in Japan; Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City (K.N.M.); Kaplan Medical Center, Rehovot, Israel (N.E.B.-B.); Huntsman Cancer Institute, University of Utah, Salt Lake City (T.L.W.); Texas Oncology, U.S. Oncology Research Network, Fort Worth (N.G.C.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (A. Oaknin); Women and Infants Hospital, Providence, RI (P.A.D.); Penn Medicine, Philadelphia (M.A.M.); University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea (J.-H.N.); O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, Birmingham (C.A.L.); Oxford University Hospitals, Oxford, United Kingdom (S.N.); Washington University School of Medicine, St. Louis (A.R.H.); Kaiser Permanente Northern California, San Francisco (R.D.L., M.A.B.); and H.M. Hospitales-Centro Integral Oncológico H.M. Clara Campal, Madrid (J.G.-D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1909707DOI Listing
September 2019

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.

Gynecol Oncol 2019 08 19;154(2):420-425. Epub 2019 Jun 19.

Department of Obstetrics and Gynecology, Peggy and Charles Stephenson Cancer Center - University of Oklahoma, Oklahoma City, OK 73104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.05.013DOI Listing
August 2019

Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience.

Gynecol Oncol Rep 2019 May 5;28:120-123. Epub 2019 Apr 5.

Memorial Sloan Kettering Cancer Center, Department of Medicine, Gynecologic Medical Oncology Service, 300 East 66 St, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2019.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461565PMC
May 2019

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.

Gynecol Oncol 2019 02 22;152(2):251-258. Epub 2018 Nov 22.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weil Cornell Medical College, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.11.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613945PMC
February 2019

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

N Engl J Med 2018 12 21;379(26):2495-2505. Epub 2018 Oct 21.

From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan-Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica, Rome (G.S.) - both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona (A. Oaknin), and M.D. Anderson Cancer Centre Madrid, Madrid (A.G.-M.) - both in Spain; University of New South Wales Clinical School, Prince of Wales Hospital, Randwick, Australia (M.F.); St. Petersburg City Oncology Dispensary, St. Petersburg, Russia (A. Lisyanskaya); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Paris (A.F., A. Leary), Institut Bergonié, Comprehensive Cancer Center, Bordeaux (A.F.), and Gustave-Roussy Cancer Campus, Villejuif (A. Leary) - all in France; the Netherlands Cancer Institute, Amsterdam (G.S.S.); Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh (C.G.), the Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London (S.B.), and AstraZeneca, Cambridge (R.B.) - all in the United Kingdom; Princess Margaret Cancer Centre, Toronto (A. Oza); Memorial Sloan Kettering Cancer Center, New York (C.A.); Froedtert and the Medical College of Wisconsin, Milwaukee (W.B.); Women and Infants Hospital, Providence, RI (C.M., P.D.); Dana-Farber Cancer Institute, Boston (J.L.); and AstraZeneca, Gaithersburg, MD (E.S.L.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1810858
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1810858DOI Listing
December 2018

Phase Ib Study of Binimetinib with Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer: Final Results, Potential Biomarkers, and Extreme Responders.

Clin Cancer Res 2018 11 29;24(22):5525-5533. Epub 2018 May 29.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0494DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616528PMC
November 2018

Association of ß-hCG Surveillance with Emotional, Reproductive, and Sexual Health in Women Treated for Gestational Trophoblastic Neoplasia.

J Womens Health (Larchmt) 2018 03 21;27(3):387-393. Epub 2017 Dec 21.

1 Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center , New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jwh.2016.6208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865249PMC
March 2018

Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation.

Gynecol Oncol Rep 2017 Nov 6;22:9-12. Epub 2017 Sep 6.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2017.09.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596333PMC
November 2017

Corrigendum to "Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation" [Gynecol. Oncol. Rep. 22 (2017) 9-12].

Gynecol Oncol Rep 2017 11 29;22:118. Epub 2017 Sep 29.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2017.09.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741775PMC
November 2017

Niraparib in Recurrent Ovarian Cancer.

N Engl J Med 2017 02;376(8):801

Memorial Sloan Kettering Cancer Center, New York, NY

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1616633DOI Listing
February 2017

Tumor Inhibition by Enzalutamide in a Xenograft Model of Ovarian Cancer.

Cancer Invest 2016 Nov 8;34(10):517-520. Epub 2016 Nov 8.

b Department of Medicine , Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, and Weill Cornell Medical College , New York , New York , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2016.1242598DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546102PMC
November 2016

Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

J Clin Oncol 2016 07 23;34(19):2279-86. Epub 2016 May 23.

Bradley J. Monk, University of Arizona Cancer Center at Dignity Health St Joseph's Hospital and Medical Center, Phoenix, AZ; Michael W. Sill, Roswell Park Cancer Institute, Buffalo; Carol Aghajanian, Memorial Sloan Kettering Cancer Center, New York, NY; Joan L. Walker, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Christopher J. Darus, Maine Medical Center, Portland, ME; Gregory Sutton, Washington University School of Medicine, St. Louis, MO; Krishnansu S. Tewari, University of California Irvine Medical Center, Orange; Jai Balkissoon, Pharmaceutical Product Development International, South San Francisco, CA; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; Jeanne M. Schilder, Indiana University Medical Center, Indianapolis, IN; and Robert L. Coleman, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.8153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962710PMC
July 2016

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.

Gynecol Oncol 2016 Mar 9;140(3):436-42. Epub 2016 Jan 9.

Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.01.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767587PMC
March 2016

A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Int J Gynecol Cancer 2016 Feb;26(2):255-60

Departments of *Medicine and †Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY; ‡Sanofi Statistics Department, Cambridge MA; and §Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009457PMC
February 2016

A systematic review of ovarian cancer and fear of recurrence.

Palliat Support Care 2015 Dec 2;13(6):1771-80. Epub 2015 Mar 2.

Memorial Sloan Kettering Cancer Center,New York,New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1478951515000127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995592PMC
December 2015

Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer.

J Clin Oncol 2015 Dec 31;33(34):4099-105. Epub 2015 Aug 31.

Rachel N. Grisham, Brooke E. Sylvester, Helen Won, Deborah DeLair, Zhan Yao, Ronglai Shen, Fanny Dao, Faina Bogomolniy, Vicky Makker, Evis Sala, Tara E. Soumerai, David M. Hyman, Douglas A. Levine, Neal Rosen, Michael F. Berger, David R. Spriggs, Carol A. Aghajanian, David B. Solit, and Gopa Iyer, Memorial Sloan Kettering Cancer Center; Rachel N. Grisham, Gregory McDermott, Vicky Makker, David M. Hyman, Neal Rosen, Michael F. Berger, David R. Spriggs, Carol A. Aghajanian, David B. Solit, and Gopa Iyer, Weill Cornell Medical College; Ricardo Ramirez, Graduate School of Medical Sciences; Nicholas D. Socci and Agnes Viale, Michael F. Berger, and David B. Solit, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, New York, NY; David M. Gershenson, University of Texas MD Anderson Cancer Center, Houston, TX; and John Farley, St Joseph's Hospital and Medical Center, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/34/4099.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.62.4726
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669594PMC
December 2015

Ovarian clear cell carcinoma, outcomes by stage: the MSK experience.

Gynecol Oncol 2015 Nov 25;139(2):236-41. Epub 2015 Sep 25.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632203PMC
November 2015

Development of a risk stratification system to guide treatment for female germ cell tumors.

Gynecol Oncol 2015 Sep 24;138(3):566-72. Epub 2015 Jun 24.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258153005
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2015.06.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012648PMC
September 2015

The role of systemic chemotherapy in the management of granulosa cell tumors.

Gynecol Oncol 2015 Mar 26;136(3):505-11. Epub 2014 Dec 26.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.12.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532352PMC
March 2015

Identification of six new susceptibility loci for invasive epithelial ovarian cancer.

Authors:
Karoline B Kuchenbaecker Susan J Ramus Jonathan Tyrer Andrew Lee Howard C Shen Jonathan Beesley Kate Lawrenson Lesley McGuffog Sue Healey Janet M Lee Tassja J Spindler Yvonne G Lin Tanja Pejovic Yukie Bean Qiyuan Li Simon Coetzee Dennis Hazelett Alexander Miron Melissa Southey Mary Beth Terry David E Goldgar Saundra S Buys Ramunas Janavicius Cecilia M Dorfling Elizabeth J van Rensburg Susan L Neuhausen Yuan Chun Ding Thomas V O Hansen Lars Jønson Anne-Marie Gerdes Bent Ejlertsen Daniel Barrowdale Joe Dennis Javier Benitez Ana Osorio Maria Jose Garcia Ian Komenaka Jeffrey N Weitzel Pamela Ganschow Paolo Peterlongo Loris Bernard Alessandra Viel Bernardo Bonanni Bernard Peissel Siranoush Manoukian Paolo Radice Laura Papi Laura Ottini Florentia Fostira Irene Konstantopoulou Judy Garber Debra Frost Jo Perkins Radka Platte Steve Ellis Andrew K Godwin Rita Katharina Schmutzler Alfons Meindl Christoph Engel Christian Sutter Olga M Sinilnikova Francesca Damiola Sylvie Mazoyer Dominique Stoppa-Lyonnet Kathleen Claes Kim De Leeneer Judy Kirk Gustavo C Rodriguez Marion Piedmonte David M O'Malley Miguel de la Hoya Trinidad Caldes Kristiina Aittomäki Heli Nevanlinna J Margriet Collée Matti A Rookus Jan C Oosterwijk Laima Tihomirova Nadine Tung Ute Hamann Claudine Isaccs Marc Tischkowitz Evgeny N Imyanitov Maria A Caligo Ian G Campbell Frans B L Hogervorst Edith Olah Orland Diez Ignacio Blanco Joan Brunet Conxi Lazaro Miquel Angel Pujana Anna Jakubowska Jacek Gronwald Jan Lubinski Grzegorz Sukiennicki Rosa B Barkardottir Marie Plante Jacques Simard Penny Soucy Marco Montagna Silvia Tognazzo Manuel R Teixeira Vernon S Pankratz Xianshu Wang Noralane Lindor Csilla I Szabo Noah Kauff Joseph Vijai Carol A Aghajanian Georg Pfeiler Andreas Berger Christian F Singer Muy-Kheng Tea Catherine M Phelan Mark H Greene Phuong L Mai Gad Rennert Anna Marie Mulligan Sandrine Tchatchou Irene L Andrulis Gord Glendon Amanda Ewart Toland Uffe Birk Jensen Torben A Kruse Mads Thomassen Anders Bojesen Jamal Zidan Eitan Friedman Yael Laitman Maria Soller Annelie Liljegren Brita Arver Zakaria Einbeigi Marie Stenmark-Askmalm Olufunmilayo I Olopade Robert L Nussbaum Timothy R Rebbeck Katherine L Nathanson Susan M Domchek Karen H Lu Beth Y Karlan Christine Walsh Jenny Lester Alexander Hein Arif B Ekici Matthias W Beckmann Peter A Fasching Diether Lambrechts Els Van Nieuwenhuysen Ignace Vergote Sandrina Lambrechts Ed Dicks Jennifer A Doherty Kristine G Wicklund Mary Anne Rossing Anja Rudolph Jenny Chang-Claude Shan Wang-Gohrke Ursula Eilber Kirsten B Moysich Kunle Odunsi Lara Sucheston Shashi Lele Lynne R Wilkens Marc T Goodman Pamela J Thompson Yurii B Shvetsov Ingo B Runnebaum Matthias Dürst Peter Hillemanns Thilo Dörk Natalia Antonenkova Natalia Bogdanova Arto Leminen Liisa M Pelttari Ralf Butzow Francesmary Modugno Joseph L Kelley Robert P Edwards Roberta B Ness Andreas du Bois Florian Heitz Ira Schwaab Philipp Harter Keitaro Matsuo Satoyo Hosono Sandra Orsulic Allan Jensen Susanne Kruger Kjaer Estrid Hogdall Hanis Nazihah Hasmad Mat Adenan Noor Azmi Soo-Hwang Teo Yin-Ling Woo Brooke L Fridley Ellen L Goode Julie M Cunningham Robert A Vierkant Fiona Bruinsma Graham G Giles Dong Liang Michelle A T Hildebrandt Xifeng Wu Douglas A Levine Maria Bisogna Andrew Berchuck Edwin S Iversen Joellen M Schildkraut Patrick Concannon Rachel Palmieri Weber Daniel W Cramer Kathryn L Terry Elizabeth M Poole Shelley S Tworoger Elisa V Bandera Irene Orlow Sara H Olson Camilla Krakstad Helga B Salvesen Ingvild L Tangen Line Bjorge Anne M van Altena Katja K H Aben Lambertus A Kiemeney Leon F A G Massuger Melissa Kellar Angela Brooks-Wilson Linda E Kelemen Linda S Cook Nhu D Le Cezary Cybulski Hannah Yang Jolanta Lissowska Louise A Brinton Nicolas Wentzensen Claus Hogdall Lene Lundvall Lotte Nedergaard Helen Baker Honglin Song Diana Eccles Ian McNeish James Paul Karen Carty Nadeem Siddiqui Rosalind Glasspool Alice S Whittemore Joseph H Rothstein Valerie McGuire Weiva Sieh Bu-Tian Ji Wei Zheng Xiao-Ou Shu Yu-Tang Gao Barry Rosen Harvey A Risch John R McLaughlin Steven A Narod Alvaro N Monteiro Ann Chen Hui-Yi Lin Jenny Permuth-Wey Thomas A Sellers Ya-Yu Tsai Zhihua Chen Argyrios Ziogas Hoda Anton-Culver Aleksandra Gentry-Maharaj Usha Menon Patricia Harrington Alice W Lee Anna H Wu Celeste L Pearce Gerry Coetzee Malcolm C Pike Agnieszka Dansonka-Mieszkowska Agnieszka Timorek Iwona K Rzepecka Jolanta Kupryjanczyk Matt Freedman Houtan Noushmehr Douglas F Easton Kenneth Offit Fergus J Couch Simon Gayther Paul P Pharoah Antonis C Antoniou Georgia Chenevix-Trench

Nat Genet 2015 Feb 12;47(2):164-71. Epub 2015 Jan 12.

Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
https://www.repository.cam.ac.uk/bitstream/handle/1810/24688
Web Search
http://www.nature.com/doifinder/10.1038/ng.3185
Publisher Site
http://dx.doi.org/10.1038/ng.3185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445140PMC
February 2015

Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer.

Int J Gynecol Cancer 2014 Jul;24(6):1010-4

*Gynecologic Medical Oncology Service, Department of Medicine, †Human Oncology and Pathogenesis Program, ‡Department of Radiology, §Department of Epidemiology and Biostatistics, and ∥Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401424PMC
July 2014

Independent radiologic review: bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer.

Gynecol Oncol 2014 Apr 6;133(1):105-10. Epub 2014 Feb 6.

New York University School of Medicine, Department of Obstetrics and Gynecology, 160 East 34th Street, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.02.003DOI Listing
April 2014

Better therapeutic trials in ovarian cancer.

J Natl Cancer Inst 2014 Apr 13;106(4):dju029. Epub 2014 Mar 13.

Affiliations of authors: University of Arizona Cancer Center, Tucson, AZ (MAB); Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, Canada (CBG); Molecular Signalling Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD (ECK); Director, Policy and Advocacy, Prevent Cancer Foundation, Alexandria, VA (KOK); Pathology and Laboratory Medicine (DH) and Department of Medical Oncology (KDS), University of British Columbia, Vancouver, BC, Canada (DH); Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (CA); Department of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, MA (MJB); CR UK/UCL Cancer Trials Centre, University College London Cancer Institute, London, UK (JAL); Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada (AMO).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982885PMC
April 2014

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.

J Clin Oncol 2014 Jan 10;32(2):129-60. Epub 2013 Dec 10.

Jyoti D. Patel, Northwestern University; Blasé Polite, University of Chicago Medicine, Chicago, IL; Lada Krilov, American Society of Clinical Oncology, Alexandria, VA; Sylvia Adams and William L. Carroll, New York University Cancer Institute; Carol Aghajanian, Mark G. Kris, and Gary K. Schwartz, Memorial Sloan-Kettering Cancer Center, New York, NY; Ethan Basch, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Marcos de Lima and Mark R. Gilbert, University of Texas MD Anderson Cancer Center, Houston; Ian Thompson, University of Texas Health Science Center at San Antonio, San Antonio, TX; John L. Marshall, Lombardi Cancer Center, Washington, DC; Gregory A. Masters, Helen F. Graham Cancer Center, Newark, DE; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Sunil Sharma, Huntsman Cancer Institute, Salt Lake City, UT; Nicholas J. Vogelzang, US Oncology Research, Comprehensive Cancer Centers of Nevada, Henderson, NV; and Bruce J. Roth, Washington University in St Louis, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.7076DOI Listing
January 2014

Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.

Int J Gynecol Cancer 2013 Nov;23(9):1635-41

*Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center; †Department of Medicine, Weill Cornell Medical College; ‡Department of Epidemiology and Biostatistics, and §Department of Gynecologic Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000001DOI Listing
November 2013

Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era.

Int J Gynecol Cancer 2013 Oct;23(8):1528-34

*Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands; †Institute of Cancer Sciences, University of Manchester, United Kingdom; ‡Division of Hematology and Oncology, Harvard Medical School and Massachusetts General Hospital, Boston, MA; §Division of Gynaecology, European Institute of Oncology, Milan, Italy; ∥Department of Gynecologic Oncology and Reproductive Medicine, MD Anderson Cancer Center, Houston, TX; ¶Department of Clinical Oncology, Barts Health NHS Trust, London, United Kingdom; #Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY; **Department of Gynaecology, Newcastle University and Northern Institute for Cancer Research, Newcastle upon Tyne, United Kingdom; ††Department of Obstetrics and Gynecology, College of Medicine, Ohio State University, Columbus, OH; ‡‡Department of Gynaecologic Oncology, Royal Women's Hospital, and Melbourne University Dept of Obstetrics and Gynaecology, Australia; §§Department of Obstetrics and Gynecology, Haukeland University Hospital; and Department of Clinical Medicine, University of Bergen, Norway; and ∥∥Department of Radiation Oncology, Sunnybrook Cancer Center, Toronto, Canada.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0b013e3182a26edbDOI Listing
October 2013

Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Gynecol Oncol 2013 Apr 20;129(1):22-7. Epub 2012 Dec 20.

Dept. of Reproductive Medicine, Moores Cancer Center, University of California, San Diego School of Medicine, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.12.022DOI Listing
April 2013

Placental site trophoblastic tumor: analysis of presentation, treatment, and outcome.

Gynecol Oncol 2013 Apr 26;129(1):58-62. Epub 2012 Dec 26.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.12.029DOI Listing
April 2013

Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival.

Radiat Oncol 2013 Feb 15;8:36. Epub 2013 Feb 15.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA.

View Article

Download full-text PDF

Source
http://ro-journal.biomedcentral.com/articles/10.1186/1748-71
Publisher Site
http://dx.doi.org/10.1186/1748-717X-8-36DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608316PMC
February 2013

Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.

Gynecol Oncol 2012 Nov 28;127(2):321-5. Epub 2012 Jul 28.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.07.112DOI Listing
November 2012

Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study.

Gynecol Oncol 2012 Sep 24;126(3):424-7. Epub 2012 May 24.

Dept. of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.05.024DOI Listing
September 2012

Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a 2-cohort, phase 2 study.

Cancer 2012 May 20;118(9):2403-10. Epub 2011 Sep 20.

Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26569DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245795PMC
May 2012

Treatment of low-risk gestational trophoblastic neoplasia.

Authors:
Carol Aghajanian

J Clin Oncol 2011 Mar 24;29(7):786-8. Epub 2011 Jan 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.31.0151DOI Listing
March 2011

Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors.

Gynecol Oncol 2010 Nov 16;119(2):270-3. Epub 2010 Aug 16.

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.07.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843122PMC
November 2010

Paraneoplastic opsoclonus-myoclonus syndrome secondary to immature ovarian teratoma.

Gynecol Oncol 2010 May 7;117(2):382-4. Epub 2010 Feb 7.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2010.01.017DOI Listing
May 2010

Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors.

Gynecol Oncol 2010 Mar 24;116(3):424-9. Epub 2009 Nov 24.

Department of Medicine, Gynecology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.10.064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852374PMC
March 2010

Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors.

Clin Cancer Res 2010 Jan 22;16(1):358-66. Epub 2009 Dec 22.

Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-2103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211604PMC
January 2010

Cancer-related infertility in survivorship.

Int J Gynecol Cancer 2010 Jan;20(1):2-8

Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/IGC.0b013e3181bf7d3fDOI Listing
January 2010

Extrauterine epithelioid trophoblastic tumors presenting as primary lung carcinomas: morphologic and immunohistochemical features to resolve a diagnostic dilemma.

Am J Surg Pathol 2009 Dec;33(12):1809-14

Gynecology Service, Department of Surgery, Memorial-Sloan Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181b9cd67DOI Listing
December 2009

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.

Gynecol Oncol 2009 Nov 26;115(2):215-20. Epub 2009 Aug 26.

The Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.07.023DOI Listing
November 2009

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.

Gynecol Oncol 2009 Jul 23;114(1):26-31. Epub 2009 Apr 23.

Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.03.018DOI Listing
July 2009